The self-service health kiosk sitting in the corner of your local CVS or Walgreens has barely changed in two decades. A blood pressure cuff, maybe a weight scale, sometimes a pulse oximeter clip. These machines cost pharmacies thousands of dollars each, require regular calibration, and collect data that usually goes nowhere. Patients sit down, get a reading, glance at the numbers, and walk away.
Meanwhile, the retail health clinic market is projected to reach $8.45 billion by 2034, growing at 8.15% annually according to Precedence Research. CVS Health, Walgreens, Walmart, and Kroger are all expanding their in-store clinical capabilities. The gap between what these clinics want to do and what a 15-year-old blood pressure kiosk can deliver is getting wider every year.
Camera-based vital sign monitoring through rPPG offers a different approach: capture heart rate, respiratory rate, HRV, and SpO2 from a brief facial video on a tablet or phone. No cuffs, no clips, no hardware to maintain.
"Blood pressure is the most frequently measured vital sign in health kiosk studies, utilized in 34% of the research. Cardiovascular disease detection is the primary motivation in 56% of included studies." — Bhutani et al., Nature Scientific Reports (2025)
The pharmacy kiosk problem nobody talks about
Bhutani et al. published a systematic review in January 2025 examining health kiosks deployed between 2013 and 2023. They reviewed 36 studies from an initial pool of 5,537 articles. Their findings paint a mixed picture: while kiosks show potential for chronic disease screening, the research base has considerable gaps. Many studies lacked performance testing, user experience evaluation, and standardized development practices.
The economics are also working against legacy kiosks. The global health kiosk market sits at roughly $800 million, which is just 1.9% of the $42 billion broader kiosk industry. That small market share means limited R&D investment. Most pharmacy kiosks still rely on oscillometric blood pressure cuffs and contact-based pulse oximetry that haven't seen meaningful innovation in years.
A 2025 study published in Hypertension analyzed self-service blood pressure data from Higi kiosks deployed across U.S. retail locations. The researchers found a high blood pressure prevalence of 47.4% among kiosk users based on either self-reported diagnosis or elevated readings. The study demonstrated that kiosk-based surveillance can identify populations with poor blood pressure control at the county level. But it also highlighted a core limitation: the people using kiosks are self-selected. They already suspect they have a problem. Passive, low-friction screening would reach a broader population.
That's where contactless monitoring changes the equation. If vital sign screening doesn't require sitting down at a dedicated machine, attaching a cuff, and waiting two minutes, more people do it.
How rPPG works in a retail environment
The technology is the same whether it runs in a hospital or a pharmacy. A camera captures facial video for 30 to 60 seconds. Light penetrating the skin interacts with hemoglobin in capillary blood flow. Each cardiac cycle produces tiny fluctuations in how that light is absorbed and reflected. These fluctuations are invisible to the naked eye but measurable by image processing algorithms that extract the underlying photoplethysmographic signal.
From that signal, the system derives heart rate, heart rate variability, respiratory rate, and blood oxygen saturation. Some research groups are also working on blood pressure estimation from facial video, though accuracy remains below what's needed for clinical screening.
In a pharmacy context, the implementation could look like this: a tablet mounted at a consultation counter runs a screening app. A patient stands in front of it for 30 seconds before a pharmacist consultation. The system captures vital signs and flags abnormalities. No cuff inflation, no finger clip, no hardware replacement cycle.
| Screening method | Hardware cost per location | Maintenance | Measurement time | Vital signs captured | Patient contact required |
|---|---|---|---|---|---|
| Traditional BP kiosk | $3,000-$10,000 | Annual calibration, cuff replacement | 2-3 minutes | Blood pressure, pulse | Yes (cuff, seat) |
| Connected pulse oximeter | $50-$200 | Battery replacement | 15-30 seconds | SpO2, pulse rate | Yes (finger clip) |
| Smartphone/tablet rPPG | $0-$500 (existing device) | Software updates only | 30-60 seconds | HR, HRV, RR, SpO2 | No |
| Wearable screening station | $500-$2,000 | Charging, sensor replacement | 1-2 minutes | HR, SpO2, temperature | Yes (wrist sensor) |
| Nurse-led manual screening | Staff time ($25-$50/session) | Equipment maintenance | 5-10 minutes | Full vital panel | Yes |
The cost difference is hard to ignore. A pharmacy chain with 3,000 locations spending $5,000 per kiosk is looking at $15 million in hardware alone, before maintenance. A software-based rPPG solution running on existing pharmacy tablets collapses that to a licensing fee.
What the research actually supports right now
It's worth being honest about where the technology stands, because the gap between what's published and what's ready for deployment matters in a clinical screening context.
Heart rate measurement from facial video is the most validated rPPG application. Multiple studies have demonstrated accuracy within ±2-5 BPM of reference devices in controlled conditions. Pirzada et al. published a review in IEEE Sensors Journal (2024) cataloging the state of rPPG for heart rate and blood oxygenation, finding that deep learning approaches have closed much of the accuracy gap with contact sensors.
Di Lernia et al. (2024) tested rPPG performance "in the wild" using online webcam feeds under uncontrolled conditions. Their results from the study published in Behavior Research Methods showed that modern algorithms maintain reasonable accuracy outside laboratory environments. This finding is directly relevant to pharmacy settings, where lighting varies and patients don't sit perfectly still.
The VA's EHRM Integration Office ran a study (NCT06536647) on contactless vital sign assessment using rPPG in a healthcare setting, evaluating the technology's feasibility for routine clinical use. The study assessed whether video-based vital sign collection could be integrated into existing clinical workflows.
SpO2 from facial video is less mature. Published results show wider error margins compared to contact pulse oximetry, particularly across diverse skin tones. Ba et al. (2023) raised equity concerns about rPPG signal quality varying with melanin content, a finding that carries direct implications for screening tools deployed in diverse retail environments.
Blood pressure remains the biggest open question. Several research groups, including teams at the University of Toronto and TU Eindhoven, have published results showing correlation between facial video analysis and cuff-based measurements. But the error margins are too wide for a screening tool that needs to reliably flag hypertension. This is a problem because blood pressure is the vital sign that pharmacy kiosks are primarily used for.
The retail health landscape is shifting underneath the old model
CVS Health reported double-digit earnings growth projections for 2026, with continued expansion of its HealthHUB and MinuteClinic operations. Walgreens has invested in clinical services alongside its pharmacy business. These companies are building out more sophisticated clinical offerings that go beyond the old model of a standalone kiosk in the corner.
The pharmacies and healthcare stores market is projected to grow from $1.28 trillion in 2025 to over $1.5 trillion by 2030, according to ResearchAndMarkets.com. Within that market, the shift toward clinical services delivered inside retail locations is accelerating. Pharmacists are increasingly authorized to prescribe, screen, and manage chronic conditions. That expanded scope creates demand for better screening tools that fit into a pharmacist's workflow rather than sitting passively in a waiting area.
A camera-based system that runs during a pharmacist consultation captures vital signs as a byproduct of the visit, not as a separate action the patient needs to take. That distinction matters. The Higi kiosk data showed that self-selected kiosk users already skew toward people who suspect a problem. Passive screening catches everyone.
Where this goes from here
The realistic near-term trajectory is a split approach. rPPG handles pulse-based screening (heart rate, HRV, respiratory rate) where the validation data supports it. Blood pressure continues to require a cuff until the accuracy data catches up. SpO2 measurement sits in between, usable for trending but not yet reliable enough to replace a finger clip for clinical decision-making.
For pharmacy chains, the appeal of camera-based screening isn't just cost reduction. It's data flow. A traditional kiosk generates a paper printout or a number on a screen. A software-based system can route readings into pharmacy management platforms, flag patients for pharmacist follow-up, and build longitudinal records over time. That integration is what turns a one-off reading into a screening program.
Circadify has developed camera-based vital sign monitoring technology that captures heart rate, respiratory rate, HRV, and SpO2 from standard cameras. The technology runs on existing tablets and smartphones, and can be deployed in retail and pharmacy environments without additional hardware.
The pharmacy kiosk had a good run. But a $5,000 machine that measures one vital sign and prints a receipt is not the future of retail health screening. The camera that's already in the building is.
Frequently asked questions
Can rPPG replace blood pressure kiosks in pharmacies?
For heart rate and respiratory rate, rPPG is approaching the accuracy needed for screening purposes. Blood pressure estimation from facial video remains an active research area with wider error margins than cuff-based kiosks. The most likely near-term scenario is rPPG handling pulse-based screening while traditional cuffs remain for blood pressure.
What vital signs can camera-based screening measure in a retail setting?
Current rPPG technology can extract heart rate, heart rate variability, respiratory rate, and blood oxygen saturation from a 30-60 second facial video captured on a smartphone or tablet. Blood pressure estimation is under development but not yet accurate enough for clinical screening.
Do patients need to download an app for camera-based vital sign screening?
Implementation varies. Some systems use dedicated apps, while others run through web browsers or are embedded in existing pharmacy health platforms. The key requirement is a device with a front-facing camera and adequate lighting.
How much do pharmacy health kiosks cost compared to camera-based alternatives?
Traditional health screening kiosks cost between $3,000 and $10,000 per unit, plus ongoing maintenance and calibration. Camera-based rPPG screening runs on existing tablets or smartphones, reducing hardware costs to near zero. The primary cost shifts to software licensing and integration.
Related articles
- What is rPPG Technology? — The full overview of remote photoplethysmography and how it extracts vital signs from video.
- Contactless Heart Rate Monitoring with rPPG Technology — A deeper look at the most validated rPPG measurement and its accuracy data.
- Workplace Wellness and Contactless Health Screening — How similar camera-based screening is being deployed in corporate and occupational health settings.